| 19.31 -0.25 (-1.28%) | 10-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23.36  |
1-year : | 27.28 |
| Resists | First : | 20 |
Second : | 23.36 |
| Pivot price | 18.99 |
|||
| Supports | First : | 18.24 |
Second : | 17.16 |
| MAs | MA(5) : | 19.42  |
MA(20) : | 18.64 |
| MA(100) : | 18.46 |
MA(250) : | 17.43 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 78.6 |
D(3) : | 80.3 |
| RSI | RSI(14): 60.4 |
|||
| 52-week | High : | 20 | Low : | 14.97 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KVUE ] has closed below upper band by 37.8%. Bollinger Bands are 71.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 20.06 - 20.17 | 20.17 - 20.26 |
| Low: | 18.87 - 19.03 | 19.03 - 19.15 |
| Close: | 19.08 - 19.31 | 19.31 - 19.5 |
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Sat, 31 Oct 2026
KVUE | Kenvue Inc. Stock Overview (Austria: Vienna) - Barron's
Fri, 30 Oct 2026
Kenvue Inc. (KVUE) Stock Forecasts - Yahoo Finance
Fri, 30 Oct 2026
Kenvue Inc. stock falls Friday, still outperforms market - MarketWatch
Fri, 30 Oct 2026
Kenvue (KVUE) Delisting as Kimberly-Clark Acquisition Completes, Dividend Sustainability in Focus - GuruFocus
Fri, 30 Oct 2026
Kenvue (NYSE:KVUE) Posts Mixed Q3 2026 Results as Organic Growth and Kimberly-Clark Deal Offset EPS Miss - ChartMill
Fri, 30 Oct 2026
Kenvue misses third-quarter profit expectations - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 1,920 (M) |
| Shares Float | 1,920 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 96 (%) |
| Shares Short | 57,660 (K) |
| Shares Short P.Month | 72,140 (K) |
| EPS | 0.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.5 |
| Profit Margin | 10.7 % |
| Operating Margin | 19.4 % |
| Return on Assets (ttm) | 6.9 % |
| Return on Equity (ttm) | 15.5 % |
| Qtrly Rev. Growth | 3 % |
| Gross Profit (p.s.) | 4.68 |
| Sales Per Share | 8.02 |
| EBITDA (p.s.) | 1.81 |
| Qtrly Earnings Growth | 8.5 % |
| Operating Cash Flow | 2,320 (M) |
| Levered Free Cash Flow | 1,910 (M) |
| PE Ratio | 22.45 |
| PEG Ratio | 1.5 |
| Price to Book value | 3.51 |
| Price to Sales | 2.4 |
| Price to Cash Flow | 15.98 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|